NCT00375219 · Interventional trial
Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
Overall registry status Completed
Phase 2
Conditions Chronic Myeloid Leukemia
Delaware Valley sites
- Teva Investigational Site 010 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory